Trial Summary
What is the purpose of this trial?The investigators are testing the efficacy of Smartphone-delivered cognitive behavioral therapy (CBT) treatment for major depressive disorder (MDD). The investigators hypothesize that participants receiving app-CBT will have greater improvement in SIGH-D scores than those in the waitlist condition at treatment endpoint (week 8).
Eligibility Criteria
This trial is for adults over 18 with Major Depressive Disorder (MDD) who live in the US and haven't had much CBT before. They must be stable on any current meds, not have severe substance issues, or acute suicidal thoughts. Tech literacy and owning a smartphone with data are required.Inclusion Criteria
I am 18 years old or older.
Currently living in the United States
I have been diagnosed with major depression.
Exclusion Criteria
I have never been diagnosed with bipolar disorder or psychosis.
I am currently receiving psychological therapy.
I have attended at least 4 CBT sessions for depression.
+5 more
Participant Groups
The study tests if using a smartphone app to do cognitive behavioral therapy (CBT) helps people with MDD feel better compared to those just waiting for treatment. It's measured by changes in depression scores after 8 weeks.
2Treatment groups
Experimental Treatment
Group I: Smartphone-delivered CBT for MDDExperimental Treatment1 Intervention
8-week Smartphone delivered CBT for MDD.
Group II: 8 Week Waitlist ControlExperimental Treatment1 Intervention
8-week waitlist control. (Note: participants will be crossed over to 8-week Smartphone-delivered CBT for MDD following the 8-week waitlist control).
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Massachusetts General HospitalBoston, MA
Loading ...
Who Is Running the Clinical Trial?
Massachusetts General HospitalLead Sponsor
Koa Health B.V.Industry Sponsor